MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET 2019-2028

Lifesciences | Pharmaceuticals

MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET 2019-2028

Market by Animal Type, Distribution Channel, Route of Administration, Product, and Country | Forecast 2019-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton Market Research’s report, the veterinary medicines market in the Middle East and Africa is predicted to develop at a compound annual growth rate of 4.06% throughout the years 2019-2028.



Report scope can be customized per your requirements. Request For Customization

The countries considered for analysis in this market are:

•        The United Arab Emirates

•        Turkey

•        South Africa

•        Saudi Arabia

•        Rest of Middle East & Africa

The Middle East and Africa serve as an emerging market for veterinary medicines as animal healthcare spending is expected to enhance during the estimated years 2019-2028. Additionally, the region has observed the highest economic growth over the years, owing to the multiple economic reforms, in turn, generating opportunities for the animal healthcare industry. Above all, the rise in the occurrence of several medical conditions in animals is further enhancing the demand for veterinary medicines. Therefore, such factors are anticipated to drive the veterinary medicines market’s progress in the Middle East and Africa region.

In Saudi Arabia, the growing awareness associated with animal healthcare is predicted to expand the demand for veterinary medicines. Moreover, the presence of established market players is expected to result in the steady growth of the studied market across the country. The demand for veterinary products is also likely to grow due to the growing number of livestock and companion animals. Hence, the above-stated factors hold the potential to offer multiple opportunities to the veterinary medicines market in Saudi Arabia.

Virbac SA operates as an independent pharmaceutical laboratory dedicated to animal health. It provides a comprehensive range of products and services, including medicines for companion and food-processing animals. Virbac innovation based on technological advances and consumer feedback is dependent on reactive production facilities, meeting higher international quality standards. With several years of experience, the company has built personalized relations with veterinarians and farmers across various countries. It has its presence across several regions, including the Middle East and Africa region.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT
ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028
Lifesciences

ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028

Market by Type, Application, E ..

VIEW REPORT

Table of Content

1.    MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   THREAT OF COMPETITIVE RIVALRY

2.3. INDUSTRY COMPONENTS

2.4. LEGAL POLICY AND REGULATORY FRAMEWORK

2.5. IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET

2.6. MARKET ATTRACTIVENESS INDEX

2.7. KEY INSIGHT

2.8. MARKET DRIVERS

2.8.1.   RISE IN LIVESTOCK PRODUCTION

2.8.2.   SURGE IN VARIOUS MEDICAL CONDITIONS IN ANIMALS

2.8.3.   INCREASING OWNERSHIP OF PETS

2.9. MARKET RESTRAINTS

2.9.1.   ADVERSE EFFECTS OF POST-VACCINATION

2.9.2.   LACK OF ADEQUATE NUMBER OF VETERINARIANS

2.10.  MARKET OPPORTUNITIES

2.10.1.  GROWING ANIMAL HEALTHCARE EXPENDITURE

2.10.2. INCREASING DEMAND FOR VETERINARY SPECIALIZATION

2.11.  MARKET CHALLENGES

2.11.1. STRINGENT REGULATIONS

2.11.2. HIGH COST OF ANIMAL VACCINES

3.    MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET OUTLOOK -BY ANIMAL TYPE

3.1. COMPANION ANIMALS

3.2. LIVESTOCK ANIMALS

4.    MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET OUTLOOK - BY DISTRIBUTION CHANNEL

4.1. RETAIL VETERINARY PHARMACIES

4.2. VETERINARY HOSPITAL PHARMACIES

5.    MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION

5.1. PARENTERAL ROUTE

5.2. ORAL ROUTE

5.3. TOPICAL ROUTE

6.    MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET OUTLOOK - BY PRODUCT

6.1. DRUGS

6.1.1.   ANTI-INFECTIVE

6.1.2.   ANTI-INFLAMMATORY

6.1.3.   PARASITICIDE

6.2. VACCINES

6.2.1.   INACTIVATED VACCINES

6.2.2.   ATTENUATED VACCINES

6.2.3.   RECOMBINANT VACCINES

6.3. MEDICATED FEED ADDITIVES

6.3.1.   ANTIBIOTICS

6.3.2.   AMINO ACIDS

7.    GEOGRAPHICAL ANALYSIS - MIDDLE EAST AND AFRICA

7.1. COUNTRY ANALYSIS

7.1.1.   SAUDI ARABIA

7.1.2.   UNITED ARAB EMIRATES

7.1.3.   TURKEY

7.1.4.   SOUTH AFRICA

7.1.5.   REST OF MIDDLE EAST & AFRICA

8.    COMPANY PROFILES

8.1. EVONIK INDUSTRIES AG (RAG STIFTUNG)

8.2. INDIAN IMMUNOLOGICALS LIMITED

8.3. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH

8.4. MERCK & CO

8.5. ZOETIS

8.6. BIOGENESIS BAGO SA

8.7. VETOQUINOL (SOPARFIN SCA)

8.8. ARCHER DANIELS MIDLAND

8.9. CEVA SANTE ANIMALE

8.10.   VIRBAC SA

8.11.   DECHRA PHARMACEUTICALS PLC

8.12.   NEOGEN CORPORATION

8.13. ELANCO

8.14.  HESTER BIOSCIENCES LIMITED

8.15.  KINDRED BIOSCIENCES

9.    RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.1.1.   OBJECTIVES OF STUDY

9.1.2.   SCOPE OF STUDY

9.2. SOURCES OF DATA

9.2.1.   PRIMARY DATA SOURCES

9.2.2.   SECONDARY DATA SOURCES

9.3. RESEARCH METHODOLOGY

9.3.1.   EVALUATION OF PROPOSED MARKET

9.3.2.   IDENTIFICATION OF DATA SOURCES

9.3.3.   ASSESSMENT OF MARKET DETERMINANTS

9.3.4.   DATA COLLECTION

9.3.5.   DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1: MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)

TABLE 2: MIDDLE EAST AND AFRICA VETERINARY MEDICINES, BY ANIMAL TYPE, 2019-2028 (IN $ MILLION)

TABLE 3: MIDDLE EAST AND AFRICA VETERINARY MEDICINES, BY DISTRIBUTION CHANNEL, 2019-2028 (IN $ MILLION)

TABLE 4: MIDDLE EAST AND AFRICA VETERINARY MEDICINES, BY ROUTE OF ADMINISTRATION, 2019-2028 (IN $ MILLION)

TABLE 5: MIDDLE EAST AND AFRICA VETERINARY MEDICINES, BY PRODUCT, 2019-2028 (IN $ MILLION)

TABLE 6: MIDDLE EAST AND AFRICA DRUGS MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 7: MIDDLE EAST AND AFRICA VACCINES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 8: MIDDLE EAST AND AFRICA MEDICATED FEED ADDITIVES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 9: MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)

List of Figures

FIGURE 1: MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 2: MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET, BY COMPANION ANIMALS, 2019-2028 (IN $ MILLION)

FIGURE 3: MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET, BY LIVESTOCK ANIMALS, 2019-2028 (IN $ MILLION)

FIGURE 4: MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET, BY RETAIL VETERINARY PHARMACIES, 2019-2028 (IN $ MILLION)

FIGURE 5: MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET, BY VETERINARY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)

FIGURE 6: MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET, BY PARENTERAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 7: MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET, BY ORAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 8: MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET, BY TOPICAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 9: MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET, BY DRUGS, 2019-2028 (IN $ MILLION)

FIGURE 10: MIDDLE EAST AND AFRICA DRUGS MARKET, BY ANTI-INFECTIVE, 2019-2028 (IN $ MILLION)

FIGURE 11: MIDDLE EAST AND AFRICA DRUGS MARKET, BY ANTI-INFLAMMATORY, 2019-2028 (IN $ MILLION)

FIGURE 12: MIDDLE EAST AND AFRICA DRUGS MARKET, BY PARASITICIDE, 2019-2028 (IN $ MILLION)

FIGURE 13: MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET, BY VACCINES, 2019-2028 (IN $ MILLION)

FIGURE 14: MIDDLE EAST AND AFRICA VACCINES MARKET, BY INACTIVATED VACCINES, 2019-2028 (IN $ MILLION)

FIGURE 15: MIDDLE EAST AND AFRICA VACCINES MARKET, BY ATTENUATED VACCINES, 2019-2028 (IN $ MILLION)

FIGURE 16: MIDDLE EAST AND AFRICA VACCINES MARKET, BY RECOMBINANT VACCINES, 2019-2028 (IN $ MILLION)

FIGURE 17: MIDDLE EAST AND AFRICA VETERINARY MEDICINES MARKET, BY MEDICATED FEED ADDITIVES, 2019-2028 (IN $ MILLION)

FIGURE 18: MIDDLE EAST AND AFRICA MEDICATED FEED ADDITIVES MARKET, BY ANTIBIOTICS, 2019-2028 (IN $ MILLION)

FIGURE 19: MIDDLE EAST AND AFRICA MEDICATED FEED ADDITIVES MARKET, BY AMINO ACIDS, 2019-2028 (IN $ MILLION)

FIGURE 20: SAUDI ARABIA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 21: UNITED ARAB EMIRATES VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 22: TURKEY VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 23: SOUTH AFRICA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 24: REST OF MIDDLE EAST & AFRICA VETERINARY MEDICINES MARKET 2019-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying